Prosecution Insights
Last updated: July 05, 2026
Application No. 17/734,869

METERED DOSE FOR DISORDERS IN OR AROUND THE EYE

Non-Final OA
Filed
May 02, 2022
Priority
Nov 04, 2019 — provisional 62/930,484 +1 more
Examiner
VIGIL, TORIANA NICHOLE
Art Unit
1612
Tech Center
1600 — Biotechnology & Organic Chemistry
Assignee
Azura Ophthalmics Ltd.
OA Round
3 (Non-Final)
51%
Grant Probability
Moderate
3-4
OA Rounds
0m
Est. Remaining
67%
With Interview

Examiner Intelligence

Grants 51% of resolved cases
51%
Career Allowance Rate
25 granted / 49 resolved
-9.0% vs TC avg
Strong +16% interview lift
Without
With
+16.3%
Interview Lift
resolved cases with interview
Typical timeline
3y 2m
Avg Prosecution
34 currently pending
Career history
105
Total Applications
across all art units

Statute-Specific Performance

§103
71.2%
+31.2% vs TC avg
§102
0.4%
-39.6% vs TC avg
§112
1.7%
-38.3% vs TC avg
Black line = Tech Center average estimate • Based on career data from 49 resolved cases

Prosecution Timeline

Show 2 earlier events
Jul 02, 2025
Interview Requested
Jul 09, 2025
Examiner Interview Summary
Sep 15, 2025
Response Filed
Nov 12, 2025
Final Rejection mailed
Feb 11, 2026
Request for Continued Examination
Feb 14, 2026
Response after Non-Final Action
Feb 19, 2026
Response Filed
Apr 01, 2026
Non-Final Rejection mailed (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12667100
COMPOSITION COMPRISING BENZYLAMINE ACARICIDE AND USE THEREOF
2y 11m to grant Granted Jun 30, 2026
Patent 12653191
ACTIVE COMPOUND COMBINATIONS
3y 6m to grant Granted Jun 16, 2026
Patent 12655070
STABLE MICRONUTRIENT COMPLEX FOR USE IN AGRICULTURAL APPLICATIONS
3y 4m to grant Granted Jun 16, 2026
Patent 12653838
METHODS OF OTOPROTECTION AGAINST PLATINUM-BASED ANTINEOPLASTIC AGENTS
3y 0m to grant Granted Jun 16, 2026
Patent 12629354
SUSTAINED-RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING OF A SEDATIVE DRUG AND USES THEREOF
5y 2m to grant Granted May 19, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
51%
Grant Probability
67%
With Interview (+16.3%)
3y 2m (~0m remaining)
Median Time to Grant
High
PTA Risk
Based on 49 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month